CorMedix, Inc. (CRMD)
7.19
-0.23
(-3.10%)
USD |
NASDAQ |
Oct 02, 16:00
7.185
0.00 (0.00%)
Pre-Market: 20:00
CorMedix Price to Book Value : 1.212 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.212 |
| October 01, 2026 | 1.250 |
| September 30, 2026 | 1.298 |
| September 29, 2026 | 1.336 |
| September 28, 2026 | 1.330 |
| September 25, 2026 | 1.323 |
| September 24, 2026 | 1.310 |
| September 23, 2026 | 1.296 |
| September 22, 2026 | 1.311 |
| September 21, 2026 | 1.310 |
| September 18, 2026 | 1.301 |
| September 17, 2026 | 1.313 |
| September 16, 2026 | 1.318 |
| September 15, 2026 | 1.308 |
| September 14, 2026 | 1.330 |
| September 11, 2026 | 1.319 |
| September 10, 2026 | 1.342 |
| September 09, 2026 | 1.370 |
| September 08, 2026 | 1.379 |
| September 04, 2026 | 1.421 |
| September 03, 2026 | 1.428 |
| September 02, 2026 | 1.451 |
| September 01, 2026 | 1.412 |
| August 31, 2026 | 1.392 |
| August 28, 2026 | 1.399 |
| Date | Value |
|---|---|
| August 27, 2026 | 1.400 |
| August 26, 2026 | 1.414 |
| August 25, 2026 | 1.443 |
| August 24, 2026 | 1.396 |
| August 21, 2026 | 1.382 |
| August 20, 2026 | 1.387 |
| August 19, 2026 | 1.436 |
| August 18, 2026 | 1.377 |
| August 17, 2026 | 1.293 |
| August 14, 2026 | 1.271 |
| August 13, 2026 | 1.372 |
| August 12, 2026 | 1.197 |
| August 11, 2026 | 1.230 |
| August 10, 2026 | 1.269 |
| August 07, 2026 | 1.254 |
| August 06, 2026 | 1.266 |
| August 05, 2026 | 1.249 |
| August 04, 2026 | 1.267 |
| August 03, 2026 | 1.272 |
| July 31, 2026 | 1.269 |
| July 30, 2026 | 1.262 |
| July 29, 2026 | 1.212 |
| July 28, 2026 | 1.239 |
| July 27, 2026 | 1.281 |
| July 24, 2026 | 1.326 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Filana Therapeutics, Inc. | 0.707 |
| Eloxx Pharmaceuticals, Inc. | 1.349 |
| BioStem Technologies, Inc. | 1.762 |
| Wave Life Sciences, Inc. | 1.611 |
| Axsome Therapeutics, Inc. | 112.54 |
Price to Book Value Related Metrics
| PE Ratio | 3.416 |
| PS Ratio | 1.422 |
| PEG Ratio | 0.0188 |
| Price to Free Cash Flow | 2.628 |
| Price | 7.19 |
| Earnings Yield | 29.27% |
| Market Cap | 558.43M |
| PEGY Ratio | 0.0188 |
| Operating PE Ratio | 3.028 |
| Normalized PE Ratio | 3.265 |